Article
Review Article

Muniswamygowda Chaitra*, Kusu Susan Cyriac, K. M Sridhar, Narayana Harsha Vardhini, Aishwarya Nagappa Malakkanavar, Anyembe Godfrey, Sridhar Mahesh Kumar Chinthakunta

Department of Pharmacology, Karnataka College of Pharmacy, #33/2 Thirumenahalli, Hegde Nagar, Bengaluru, Karnataka, India.

Author for correspondence

Muniswamygowda Chaitra

Department of Pharmacology,

Karnataka College of Pharmacy,

#33/2 Thirumenahalli, Hegde Nagar,

Bengaluru, Karnataka, India

Email: chaitra.m666@gmail.com 

Year: 2019, Volume: 9, Issue: 2, Page no. 3-9,
Views: 778, Downloads: 17
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Atopic dermatitis (AD) is described by perpetual profoundly pruritic and backsliding incen-diary skin injuries. In spite of its developing predominance, restorative medicines stay con-strained. Characteristic resistant modulators from homegrown concentrates or subsidiaries might be helpful to treat AD side effects. The seriousness of dermatitis corresponded with the serum level of complete IgE Common highlights of AD incorporate unreasonable penetration of fiery cells and granulated pole cells into AD skin sores and high immunoglobulin E (IgE) levels and leukocyte includes in blood. Remarkably, CD4+ T cells are basic for the advancement of unfavorably susceptible incendiary ailments. Some studies have shown that inducers such as- 2,4 dinitrochlorobenzene (DNCB), allergen, House dust mite (HDM) allergen, Hapten, Superantigen just to mention but a few, play a major role in the development of atopic dermatitis. Understanding the roles played by these inducers will go a long way in helping with the treatment and management of dermatitis. In this article, we review some of the roles of different inducers in the development of atopic dermatitis. 

<p>Atopic dermatitis (AD) is described by perpetual profoundly pruritic and backsliding incen-diary skin injuries. In spite of its developing predominance, restorative medicines stay con-strained. Characteristic resistant modulators from homegrown concentrates or subsidiaries might be helpful to treat AD side effects. The seriousness of dermatitis corresponded with the serum level of complete IgE Common highlights of AD incorporate unreasonable penetration of fiery cells and granulated pole cells into AD skin sores and high immunoglobulin E (IgE) levels and leukocyte includes in blood. Remarkably, CD4+ T cells are basic for the advancement of unfavorably susceptible incendiary ailments. Some studies have shown that inducers such as- 2,4 dinitrochlorobenzene (DNCB), allergen, House dust mite (HDM) allergen, Hapten, Superantigen just to mention but a few, play a major role in the development of atopic dermatitis. Understanding the roles played by these inducers will go a long way in helping with the treatment and management of dermatitis. In this article, we review some of the roles of different inducers in the development of atopic dermatitis.&nbsp;</p>
Keywords
Atopic dermatitis, immunoglobulin E, allergy, inflammation.
Downloads
  • 1
    FullTextPDF
Article

INTRODUCTION

Atopic dermatitis (AD) is a ceaseless, exceptionally pruritic (bothersome) inflammatory skin illness, and is one of the most well-known skin issues in children.1 The confusion brings about critical grimness and unfavorably influences the nature of life.2 The pathogenesis of AD isn’t seen, nonetheless, the confusion seems to result from the perplexing collaboration between deformities in skin boundary work, invulnerable dysregulation, and natural and irre-sistible agents.3,4 The pervasiveness of AD has expanded in recent years. It is as of now as-sessed that 10–20% of kids and 1–3% of grown-ups in created nations are influenced by the disorder.5 The clinical indications of AD fluctuate with age. In babies, the scalp, face, neck, trunk, and extensor (external) surfaces of the limits are commonly influenced, while the di-aper territory is typically spared.2

Different conditions that should be considered in the differential determination of AD are nourishing lacks, malignancies, and keratinization or immunodeficiency issues that are related to skin manifestations.2 Even though the pathogenesis of AD isn’t completely comprehended, it is expected that the deregulation of T-helper 1 (Th1) and T-helper2 (Th2) insusceptible reactions, a transcendence of allergen explicit IgE, and hindered epidermal boundary capacity are keys to the pathogenic component. What’s more, the unfavorably susceptible reaction is identified with pole cells, which are produced from myeloid immature microor-ganisms. RBL2H3 is a mucosal pole cell line. The elements of these cells are like those of essential pole cells and ordinary basophils. In this way, they are generally used to contemplate IgE-interceded degranulation and are viewed as a decent model for considering hostile to hypersensitive impacts.6

Illness severy affects personal satisfaction.7 The mainline medications for human AD incorporate topical glucocorticoids or calcineurin inhibitors, though foundational immunosuppressants are utilized for progressively extreme cases.8 The determination of AD depends on clinical introduction of skin erythematous plaques, emission or potentially lichenification commonly in flexural territories joined by extreme pruritus and cutaneous excessive touchi-ness. The skin injuries are related to at least one normal atopic signs, for example, palmar hyperlinearity and infraorbital overlay. Neurotic assessment uncovers spongiosis, hyper-and parakeratosis in intense sores and stamped epidermal hyperplasia, acanthosis and perivascular collection of lymphocytes and pole cells in interminable lesions.9,10

A sign of AD is dry irritated skin. It is imagined this is because of deformities in skin quali-ties that are significant for maintaining skin boundary capacity and bloat. Also, qualities that advance pruritus, for example, IL-31 or a Th2 reaction to allergens are probably going to likewise add to the pathogenesis of AD.11 Intense AD skin sores display Th2-predominant irritation described by dermal penetration of CD4+ T cells and eosinophils with the testimony of eosinophil items and expanded skin articulation of Th2 cytokines. Along these lines, the unending stage shows a nearby Th1 interferon-γ (IFN-γ) reaction and tissue redesigning with expanded testimony of collagen and dermal thickening. There are likewise expanded quanti-ties of pole cells yet for all intents and purposes no collection of neutrophils.12

Promotion can be comprehended through the investigation of creature models. Various mouse models have been created in recent decades, especially, to portray the Nc/Nga mouse as the primary immediately happening model of AD.13 These models show significant highlights of human AD, bringing about a superior comprehension of the pathogenesis of this sickness. Skin changes that firmly emulate human AD are instigated in NC/Nga mice following introduction to different ecological aeroallergens.9

ROLE OF 2,4 DINITROCHLOROBENZENE (DNCB) IN INDUCING ATOPIC DERMATITIS:

2,4 dinitrochlorobenzene (DNCB) :

A fragrant hydrocarbon made out of a benzene ring connected to two nitro gatherings and one chloride with potential use as a pointer for glutathione S-transferase (GST) action, in the assessment of T-cell resistant fitness, and as a treatment for moles. DNCB instigates a sort IV excessive touchiness response in many patients; in this way, presentation to DNCB can yield a roundabout estimation of T-cell action in a patient and immunocompromised patients may exhibit diminished extreme touchiness toward DNCB. Following a direct application to a mole, DNCB incites an unfavorably susceptible incendiary reaction that may fix the viral contamination that caused the mole.14,15

It was accounted for that 2,4 dinitrochlorobenzene (DNCB), an electrophilic and cytotoxic benzene subordinate, incites stable clinical AD-like skin maladies in NC/Nga mice.14 Skin changes in NC/Nga mice are proved by scratching conduct, trailed by the fast improvement of erythema, lichenification with edema, and haemorrhage.16,21 Histological assessments have uncovered hyperplasia and thick collection of eosinophils and pole cells in skin lesions.9,14 Alongside these skin changes, NC/Nga mice display raised degrees of absolute serum IgE.14 DNCB-incited contact touchiness pathogenesis is transcendently the aftereffect of T cell interceded invulnerable responses.16 CD4+ T cell enactment prompts the discharge of cytokines and chemokines and drives aggravation and hypersensitive sensitization.17

AD MODELS INDUCED BY EPICUTANEOUS SENSITIZATION

1. An animal model of AD induced by skin injury and epicutaneous sensitization with al-lergen:

Promotion incited by rehashed epicutaneous (EC) refinement of tape-stripped skin with ovalbumin (OVA).18 This model works in each of the five strains of mice tried to date including BALB/c and C57BL/6 mouse strains.19 The back skin of mice is shaved and tape stripped multiple times with 3M tape, mirroring skin damage delivered by scratching in patients with AD. One hundred μg of OVA in 100 μl of typical saline or 100 μl of ordinary saline is set on a 1×1 cm fix of sterile cloth, which is verified to the skin with a straightforward bio occlu-sive dressing. This guarantees the antigen isn’t open to licking.

EC sharpened mice create expanded scratching conduct and their skin creates sores portrayed by epidermal and dermal thickening, penetration of CD4+ T cells, and eosinophils and upregulated articulation of the Th2 cytokines IL-4, IL-5 and IL-13 with practically no adjustment in the articulation IFN-γ. There is an improved articulation of eotaxin and TARC, the chemokines that separately draw in CCR3+ eosinophils and skin-homing CCR4+ CD4+ T cells. There is likewise expanded testimony of collagen. Foundationally, serum OVA-explicit IgG1, IgE and IgG2a are raised, and splenocytes from OVAsharpened mice produce an expanded degree of IL-4, IL-5, IL-13, and IFN-γ because of OVA restimulation.17 The way that antigen explicit IFN-γ creating cells is available in the spleen, with no recognizable upregulation of IFN-γ articulation in sharpened skin destinations recommends that nearby factors at the site of refinement advance specifically the initiation of Th2 cells. In this regard, Thymic stromal lymphopoietin (TSLP) advances the discharge of Th2 cytokines with no perceptible impact on the emission of Th1 cytokines by TCR-OVA transgenic T cells animated in vitro with OVA peptide. What’s more OVA-sharpened mice create expanded aviation route hyperresponsiveness (AHR) following inward breath challenge with OVA, a component saw in asthmatic patients with AD history.17 Diminishing the cycles of sharpening from three to two or compacting the length of the refinement convention by diminishing the interim between the cycles of refinement prompts the imperfect improvement of unfavorably susceptible skin irritation.

As of late, we found that EC refinement with OVA drives the age of IL-17-delivering T cells in depleting lymph hubs and spleen and a neighborhood and foundational Th17 response.18,19 OVA inward breath by EC-sharpened mice instigated IL-17 and CXCL2 articulation and neutrophil deluge in the lung alongside bronchial hyperreactivity, which was turned around by IL-17 barricade.20

2. AD model prompted by EC application of House dust vermin (HDM) allergen :

Clinical examinations have given proof that HDM allergen is related to human AD21,22 BALB/c mice exposed to EC use of the recombinant bug allergen Der p8 showed highlights of dermatitis with epidermal hyperplasia and spongiosis, skin infiltration with CD4+ and CD8+ cells, and a slanted Th2 reaction locally and systemically.23 These discove-ries are like those seen in our model of EC sharpening with OVA. Immunohistochemistry uncovered the declaration of neuropeptides just in Der p8 treated the skin. Nerve filaments were seen in the nearness of pole cells in the dermis. These discoveries may propose a com-munication between the anxious and safe frameworks in the skin injury of AD.

3. Hapten induced mouse model of AD :

Haptens, for example, oxazolone (Ox) and trinitrochlorobenzene (TNCB) are normally used to actuate dermatitis and have been thought to summon principally a Th1 commanded reac-tion. In any case, it has been as of late announced that numerous difficulties with oxazolone or TNCB to the skin of smooth mice over an all-inclusive period makes the skin aggravation move from a normal Th1 commanded postponed type touchiness reaction to a constant Th2 overwhelmed incendiary reaction that is like human AD.24,25 Nine to ten difficulties with Ox to bald mice created an endless Th2-like skin irritation. The aggravation was portrayed by the dermal invasion of Th2 lymphocytes that express the PGD2 receptor CRTH, pole cells and eosinophils, expanded articulation of IL-4 in the dermis and profoundly raised IgE levels. The rehashed challenge with Ox prompted expanded epidermal hyperplasia and diminished articulation of the skin separation proteins filaggrin, loricrin, and involucrin. A skin obstruction anomaly ended up obvious and was related to diminished stratum corneum ceramide content, diminished stratum corneum hydration, transepidermal water misfortune, and hin-dered lamellar body emission, bringing about decreased lamellar films, as saw in AD patients. Moreover, as in human AD, epidermal serine protease action in SC (characterize) expanded and articulation of two lamellar body-determined antimicrobial peptides, CRAMP and mBD3, declined after Ox challenges, paralleling the abatement of their human homologs in AD skin injuries. These progressions were not seen after a solitary test with a hapten, the traditional method to evoke hapten deferred excessive touchiness response.26

Even though the hapten rehashed refinement model is certainly not hereditarily determined, a large number of its viewpoints might be relevant to extraneous allergen driven AD. In reality, it especially delineates the thought that once the allergen is presented employing a rupture in the obstruction, the subsequent allergen has driven irritation further harms the skin boundary. This amplificatory cycle may assume a significant job in the propagation and fuel of human AD. This model should be contrasted head with a protein (OVA and HDM) rehashed sharpening model. In light of its reproducibility, consistency, ease, and relative speed, the hapten rehashed sharpening model could demonstrate valuable for assessing pathogenic components and potential treatments for AD.24

4. Superantigen initiated mouse models of AD:

S.aureus colonization or contamination, the most well-known reason for AD worsens. of all S.aureus strains disconnected from lesional skin, up to 65% produce exotoxins with superan-tigenic properties. We have demonstrated that the use of SEB rather than OVA by rehashed EC sharpening to tape-stripped skin had the option to inspire Th2-overwhelmed unfavorably susceptible skin irritation joined by a fundamental Th2 reaction to the superantigen.27

OTHER MICE STRAIN WITH UNCONSTRAINED DERMATITIS :

Different strains of mice that immediately create dermatitis have been proposed as potential models of hypersensitive dermatitis. Naruto Research Institute Otsuka (NOA) mice display balding and pruritic ulcerative dermatitis with pole cell gathering in the dermis, and high serum level of IgE; notwithstanding, they need old-style histological qualities of human AD.27,28

DS-Ng mice, another innate strain that was set up 20 years back, have been ac-counted for to create unconstrained dermatitis just under customary conditions. The serious-ness of dermatitis associated with the serum level of allout IgE.29 Strangely, substantial colonization of S.aureus was found in the skin injury. Additionally, skin utilization of warmth executed S.aureus to DS-Nh mice incited comparable dermatitis. In this way, these mice could be a decent model for S.aureus related AD.30,31

CONCLUSION

The investigation of mouse models of AD has revealed significant insight into the pathogenesis of hypersensitive skin irritation. They have featured the job of mechanical damage and disturbance of the skin hindrance in unfavorably susceptible sharpening to epicutaneously presented allergens. All the more significantly they are permitting a top to the bottom analyzation of the go-betweens and cells that are basic for the advancement of the unfavorably susceptible reaction to EC refinement. The use of the information picked up by the current models of AD to these lacking mice ought to give AD models that firmly emulate the human disease.9

A few mouse strains likewise have been depicted to normally grow AD-like injuries. The most outstanding is the NC/Nga mice, in which pruritic skin sores create when they are housed under regular conditions; AD-like signs likewise precipitously happen in Flaky Tail (ft/ft) mice. The seriousness of dermatitis related to the serum level of complete IgE (Hikita et al., 2002).

There is solid proof that a hereditarily damaged skin hindrance capacity is a significant in-clining factor for AD, as represented by the perception that 15% of AD patients have a blemished filaggrin quality. Mice that have a hereditary deformity in hindrance capacity will in all likelihood give a model of AD nearer to the human ailment than models furnished by epicutaneous sharpening with allergens or haptens or by transgenic over-articulation of cyto-kines in the skin or interruption of insusceptible qualities talked about above, and will have a bit of leeway over Nc/Nga mice in which the hereditary imperfection isn’t known. In view of the perceptions that hindrance disturbance by skin damage results in Th2 overwhelmed skin irritation and on the perception that unending aggravation in ordinary mouse skin more than once sharpened with hapten upsets boundary work, we foresee that mice with hereditarily blemished obstruction work, for example, filaggrin insufficient mice, will be profoundly deli-cate to the improvement of Th2 slanted skin irritation in light of ecological antigens and that this aggravation will further intensify the skin obstruction deformity and results in the downregulation of the statement of antimicrobial qualities in the skin and inclination to bacterial development and superinfection, all highlights of human AD. We accept that the age of mice inadequate in filaggrin and other epidermal qualities that are significant for flawless skin ob-struction capacity is pending. 

Supporting Files
No Pictures
References

1. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122:812– 24.

2. McKenna SP, Doward LC. Quality of life of children with atopic dermatitis and their families. Curr Opin Allergy Clin Immunol. 2008;8:228–31.

3. Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: essential topics to prevent the atopic march. J Allergy Clin Immunol. 2016;138(2):350–8.

4. Nomura T, Kabashima K. Advances in atopic dermatitis in 2015. J Allergy Clin Immunol. 2016;138(6):1548–55.

5. Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am. 2002;22:1–25.

6. Debnath T, Lee YM, Lim JH, Lim BO. Antiallergic and anti-atopic dermatitis effects of Gardenia Fructus extract. Food and Agricultural Immunology. 2018;29(1):665–74.

7. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-1122.

8. Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, et al. S2k guideline on diagnosis and treatment of atopic dermatitis - short version. J Dtsch Dermatol Ges. 2016;14(1):92-105.

9. Jin H, He R, Oyoshi M, Geha RS. Animal Models of Atopic Dermatitis. Journal of Investigative Dermatology. 2009;129(1):31–40.

10. Oflazoglu E, Simpson EL, Takiguchi R, Grewal IS, Hanifin JM, et al. CD30 expres-sion on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity. Eur J Dermatol. 2008;18(1):41–9.

11. Morar N, Cookson WO, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007;127:1667–1672. [PubMed: 17301831]

12. Novak N, Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 2005;53: S171– 176. [PubMed: 16021172]

13. Matsuda, H., Watanabe, N., Geba, GP., Sperl, J., Tsudzuki, M., Hiroi, J.,…Ra, C. (1997). Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. International Immunology, 9(3), 461–466.

14. Jung BG, Cho SJ, Koh HB, Han DU, Lee BJ (2010) Fermented Maesil (Prunus mume) with probiotics inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Vet Dermatol 21: 184–191.

15. NCI Thesaurus [Internet]. National Institutes of Health. U.S. Department of Health and Human Services; [cited 2019Mar16]. Available from: https://ncit.nci.nih.gov/ncitbrowser/ ConceptReport.jsp?dictionary=NCI_ Thesaurus&ns=ncit&code=C439

16. Zhang EY, Chen AY, Zhu BT (2009) Mechanism of dinitrochlorobenzeneinduced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS One 4: e7703.

17. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, LangeveldWildschut AG, Ruzicka T, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1998; 19(8):359–61.

18. Spergel J, Mizoguchi E, Brewer J, Martin T, Bhan A, Geha R. Epicutaneous sensitiza-tion with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after a single exposure to aerosolized antigen in mice. J Clin Invest 1998;101:1614–1622. [PubMed: 9541491]

19. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. The Journal of clinical investigation 1999;103:1103– 1111. [PubMed: 10207161]

20. Oflazoglu E, Simpson EL, Takiguchi R, Grewal IS, Hanifin JM, Gerber HP. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity. Eur J Dermatol. 2008;18(1):41–9.

21. He R, Oyoshi MK, Jin H, Geha RS. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci U S A 2007;104:15817–15822. [PubMed: 17893340]

22. Kimura M, Tsuruta S, Yoshida T. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 1998;101:84–89. [PubMed: 9449505]

23. Huang CH, Kuo IC, Xu H, Lee YS, Chua KY. Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in the mouse. J Invest Dermatol 2003;121:289–293. [PubMed: 12880420]

24. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461–466. [PubMed: 9088984]

25. Kim, J, Lee, I, Park, S, & Choue, R. (2010). Effects of Scutellariae radix and Aloe vera gel extracts on immunoglobulin E and cytokine levels in atopic dermatitis NC/Nga mice. Journal of Ethnopharmacology, 132(2), 529–532.

26. Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, et al. Characterization of a Hapten-Induced, Murine Model with Multiple Features of Atopic Dermatitis: Structural, Immunologic, and Biochemical Changes following Single Versus Multiple Oxazolone Challenges. J Invest Dermatol. 2007

27. Laouini D, Kawamoto S, Yalcindag A, Bryce P, Mizoguchi E, Oettgen H, et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. Journal of Allergy and Clinical Immunology 2003b;112:981–987. [PubMed: 14610492]

28. Watanabe O, Natori K, Tamari M, Shiomoto Y, Kubo S, Nakamura Y. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. Journal of human genetics 1999;44:173–176. [PubMed: 10319581]

29. Hikita I, Yoshioka T, Mizoguchi T, Tsukahara K, Tsuru K, Nagai H, et al. Characteri-zation of dermatitis arising spontaneously in DSNh mice maintained under conven-tional conditions: another possible model for atopic dermatitis. J Dermatol Sci 2002;30:142–153. [PubMed: 12413770]

30. Haraguchi M, Hino M, Tanaka H, Maru M. Naturally occurring dermatitis associated with Staphylococcus aureus in DS-Nh mice. Exp Anim 1997;46:225–229. [PubMed: 9250484]

31. Lian, Q., Cheng, Y., Zhong, C., & Wang, F. (2015). Inhibition of the IgE-mediated activation of RBL-2H3 cells by TIPP, a novel thymic immunosuppressive pentapeptide. International Journal of Molecular Sciences, 16(1), 2252–2268.  

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.